These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 17684460)

  • 1. Albuminuria and chronic kidney disease in association with the metabolic syndrome.
    Ninomiya T; Kiyohara Y
    J Cardiometab Syndr; 2007; 2(2):104-7. PubMed ID: 17684460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metabolic syndrome and chronic kidney disease in U.S. adults.
    Chen J; Muntner P; Hamm LL; Jones DW; Batuman V; Fonseca V; Whelton PK; He J
    Ann Intern Med; 2004 Feb; 140(3):167-74. PubMed ID: 14757614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiometabolic syndrome and chronic kidney disease.
    Lastra G; Manrique C; McFarlane SI; Sowers JR
    Curr Diab Rep; 2006 Jun; 6(3):207-12. PubMed ID: 16898573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventing cardiovascular and renal complications in the management of hypertension and metabolic syndrome.
    Chen J; Townsend RR
    Expert Opin Pharmacother; 2007 Sep; 8(13):2001-9. PubMed ID: 17714054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Summaries for patients. Association of the metabolic syndrome and chronic kidney disease in U.S. adults.
    Ann Intern Med; 2004 Feb; 140(3):I39. PubMed ID: 14757631
    [No Abstract]   [Full Text] [Related]  

  • 6. [Impact of metabolic syndrome on chronic kidney disease].
    Calò LA
    Minerva Med; 2006 Dec; 97(6):451-8. PubMed ID: 17213781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of metabolic syndrome and chronic kidney disease.
    Scurt FG; Ganz MJ; Herzog C; Bose K; Mertens PR; Chatzikyrkou C
    Obes Rev; 2024 Jan; 25(1):e13649. PubMed ID: 37783465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subclinical Kidney Damage in Hypertensive Patients: A Renal Window Opened on the Cardiovascular System. Focus on Microalbuminuria.
    Mulè G; Castiglia A; Cusumano C; Scaduto E; Geraci G; Altieri D; Di Natale E; Cacciatore O; Cerasola G; Cottone S
    Adv Exp Med Biol; 2017; 956():279-306. PubMed ID: 27873229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal manifestations in the metabolic syndrome.
    Locatelli F; Pozzoni P; Del Vecchio L
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S81-5. PubMed ID: 16565254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Lipotoxicity on Renal Dysfunction in a Nonobese Rat Model of Metabolic Syndrome: A Urinary Proteomic Approach.
    Markova I; Miklankova D; Hüttl M; Kacer P; Skibova J; Kucera J; Sedlacek R; Kacerova T; Kazdova L; Malinska H
    J Diabetes Res; 2019; 2019():8712979. PubMed ID: 31886287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of albuminuria and the metabolic syndrome.
    Rowley K; O'Dea K; Best JD
    Curr Diab Rep; 2003 Feb; 3(1):80-6. PubMed ID: 12643150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time to abandon microalbuminuria?
    Ruggenenti P; Remuzzi G
    Kidney Int; 2006 Oct; 70(7):1214-22. PubMed ID: 16871239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity and insulin resistance as risk factors for chronic kidney disease.
    Whaley-Connell A; Pavey BS; Afroze A; Bakris GL
    J Cardiometab Syndr; 2006; 1(3):209-14; quiz 215-6. PubMed ID: 17679819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and risk factors of albuminuria and chronic kidney disease in Chinese population with type 2 diabetes and impaired glucose regulation: Shanghai diabetic complications study (SHDCS).
    Jia W; Gao X; Pang C; Hou X; Bao Y; Liu W; Wang W; Zuo Y; Gu H; Xiang K
    Nephrol Dial Transplant; 2009 Dec; 24(12):3724-31. PubMed ID: 19617258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triad of metabolic syndrome, chronic kidney disease, and coronary heart disease with a focus on microalbuminuria death by overeating.
    Gobal F; Deshmukh A; Shah S; Mehta JL
    J Am Coll Cardiol; 2011 Jun; 57(23):2303-8. PubMed ID: 21636030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic syndrome, insulin resistance, and chronic allograft dysfunction.
    Porrini E; Delgado P; Torres A
    Kidney Int Suppl; 2010 Dec; (119):S42-6. PubMed ID: 21116317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular and renal effects of weight reduction in obesity and the metabolic syndrome.
    Cohen JB; Cohen DL
    Curr Hypertens Rep; 2015 May; 17(5):34. PubMed ID: 25833456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular pathogenesis of chronic kidney disease].
    Kashihara N; Satoh M
    Nihon Rinsho; 2008 Sep; 66(9):1671-7. PubMed ID: 18788393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microalbuminuria and proximal tubule remodeling in the cardiometabolic syndrome.
    Hayden MR; Chowdhury NA; Witte L; Sowers JR
    J Cardiometab Syndr; 2006; 1(2):107-14. PubMed ID: 17679822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabolic syndrome and chronic kidney disease.
    Zhang X; Lerman LO
    Transl Res; 2017 May; 183():14-25. PubMed ID: 28025032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.